Dow and Lockheed Martin: Two Contrarian Plays in an AI-Obsessed Market

Dow and Lockheed Martin: Two Contrarian Plays in an AI-Obsessed Market

Dow and Lockheed Martin: Two Contrarian Plays in an AI-Obsessed Market

·3 min read
Share

TL;DR While AI stocks dominate headlines with triple-digit gains, Morningstar points to Dow (DOW) and Lockheed Martin (LMT) as compelling buys. Dow benefits from Strait of Hormuz disruptions cutting Asian chemical production while US plants run at full capacity. Lockheed Martin's pullback from highs creates an entry point backed by rising global defense budgets. Both pay dividends while you wait.

Two Sectors the Market Is Ignoring

The stock market in 2026 has a singular obsession: anything connected to AI. That focus has created pockets of neglect in traditional industries—and neglect, in investing, often means opportunity.

Dow and Lockheed Martin operate in decidedly unglamorous sectors: chemicals and defense. Neither will generate the kind of social media excitement that a 400% YTD gain in SanDisk does. But both are positioned to benefit from structural shifts that have nothing to do with AI and everything to do with geopolitics.

Dow (DOW): Geopolitical Disruption Creates Pricing Power

Dow is a US chemical company producing oil-derived materials used in plastics, packaging, coatings, and industrial products.

The investment thesis centers on a specific geopolitical event. The Iran conflict and disruptions to the Strait of Hormuz have created severe supply constraints for Asian chemical manufacturers who depend on Middle Eastern oil. They're cutting production because they simply can't get enough feedstock.

US companies like Dow face no such constraint. With access to domestically produced oil, Dow can run its plants at full capacity and fill the supply gap that Asian competitors are leaving behind. More volume at higher prices translates directly to improved revenue and margins.

The stock pays a 3.5% dividend yield while this thesis plays out. In a market where many growth stocks pay nothing and trade at triple-digit multiples, that income component adds meaningful value.

Lockheed Martin (LMT): A Pullback in a Structural Growth Story

Lockheed Martin builds fighter jets, missile systems, and military technology. The stock has pulled back from its highs, and the Q1 results were underwhelming—flat revenue year-over-year with slightly contracting margins.

But context matters. Q1 is historically the weakest quarter for defense companies. More importantly, the long-term demand picture hasn't deteriorated:

  • US defense budgets are not declining
  • European nations are increasing defense spending to levels not seen in decades
  • Geopolitical tensions continue to support sustained military investment globally

Defense stocks carry a fundamentally different risk profile than growth equities. Revenue is primarily government-contract-based, providing stability that few other industries can match.

Side-by-Side Comparison

FactorDow (DOW)Lockheed Martin (LMT)
SectorChemicalsDefense
CatalystHormuz disruptions weakening Asian competitorsRising global defense budgets
Dividend Yield~3.5%Dividend-paying
Key RiskGeopolitical normalization reduces advantageContinued soft quarterly results
CharacterCyclical, geopolitical beneficiaryDefensive, government-contract based
Market AttentionLowModerate

Why Contrarian Positioning Matters Now

The common thread between these two stocks is that they offer value precisely because the market is looking elsewhere.

AI-adjacent companies have priced in years of growth. Dow and Lockheed Martin have not fully priced in the structural tailwinds supporting their businesses. Both carry real risks—Dow's advantage could diminish if geopolitical conditions normalize, and Lockheed could deliver more soft quarters. But the risk-reward ratio at current prices favors the patient investor.

The best returns in markets consistently come from buying what's overlooked, not what's popular. That principle is as true in 2026 as it's ever been.

Share

Ecconomi

Finance & Economics major at a U.S. university. Securities report analyst.

Learn more
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Investment decisions should be made at your own discretion and risk.

More in this Category

Previous Posts

Ecconomi

A professional financial content platform providing in-depth analysis and investment insights on global financial markets.

Navigation

The content on this site is for informational purposes only and should not be construed as investment advice or financial guidance. Investment decisions should be made based on your own judgment and responsibility.

© 2026 Ecconomi. All rights reserved.